Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2/3 1

Status

Completed 5Unknown 2Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 1Peripheral Nervous System Diseases 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Glutamine × Clear all
NCT02282839 2015-11-04

Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation

Taichung Veterans General Hospital

Phase 3 Unknown
60 enrolled
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT02024191 2013-12-31

GELUPO

Ankara Education and Research Hospital

Phase 3 Unknown
80 enrolled

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡